At a glance
ClinicalIndex Comparison RecordPhase 4Not Yet Recruiting· 384 target
Drug / intervention
Huaier Granuledrug
Likely dose
Huaier Granule 10gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Open-label, Randomized, Controlled, Prospective Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis
In Brief
A Phase 4 clinical trial evaluating Huaier Granule for Breast Cancer Stage IV. Not yet recruiting, targeting 384 participants across 13 sites.
Detailed Summary
This is a multicenter, open-label, randomized controlled, prospective clinical study to evaluate the efficacy and safety of Huaier Granules in patients with advanced breast cancer without visceral metastasis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer Stage IV
CountriesChina
Timeline
Phase 4Not Yet Recruiting
2024202520262027
First PostedMay 2023
Enrollment StartOct 2023
Primary CompletionOct 2025
TodayJul 2026
Study CompletionOct 2027
First PostedMay 16, 2023
Enrollment StartOct 1, 2023
Primary CompletionOct 1, 2025
Study CompletionOct 1, 2027
TodayJul 1, 2026
Enrollment to primary: 2 yearsPosted 3.1 years ago
Interventions
Huaier Granuledrug
10g each time, three times a day